Literature DB >> 26835092

Arrhythmia & Electrophysiology Review - A New Era for NOAC Antidotes.

Demosthenes Katritsis1.   

Abstract

Entities:  

Year:  2015        PMID： 26835092      PMCID： PMC4711554          DOI： 10.15420/aer.2015.4.1.8

Source DB:  PubMed          Journal:  Arrhythm Electrophysiol Rev        ISSN： 2050-3369


× No keyword cloud information.
  7 in total

1.  Cost-effectiveness of oral anticoagulants for treatment of atrial fibrillation.

Authors:  William J Canestaro; Amanda R Patrick; Jerry Avorn; Kouta Ito; Olga S Matlin; Troyen A Brennan; William H Shrank; Niteesh K Choudhry
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-11-12

2.  Reversal of dabigatran anticoagulation ex vivo: Porcine study comparing prothrombin complex concentrates and idarucizumab.

Authors:  Markus Honickel; Stefanie Treutler; Joanne van Ryn; Sabine Tillmann; Rolf Rossaint; Oliver Grottke
Journal:  Thromb Haemost       Date:  2015-01-08       Impact factor: 5.249

3.  Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.

Authors:  Christian T Ruff; Robert P Giugliano; Eugene Braunwald; Elaine B Hoffman; Naveen Deenadayalu; Michael D Ezekowitz; A John Camm; Jeffrey I Weitz; Basil S Lewis; Alexander Parkhomenko; Takeshi Yamashita; Elliott M Antman
Journal:  Lancet       Date:  2013-12-04       Impact factor: 79.321

4.  Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects.

Authors:  Elise S Eerenberg; Pieter W Kamphuisen; Meertien K Sijpkens; Joost C Meijers; Harry R Buller; Marcel Levi
Journal:  Circulation       Date:  2011-09-06       Impact factor: 29.690

Review 5.  Specific antidotes in development for reversal of novel anticoagulants: a review.

Authors:  Antonio Gomez-Outes; M L Suarez-Gea; Ramon Lecumberri; Ana I Terleira-Fernandez; Emilio Vargas-Castrillon
Journal:  Recent Pat Cardiovasc Drug Discov       Date:  2014

Review 6.  Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.

Authors:  Francesco Dentali; Nicoletta Riva; Mark Crowther; Alexander G G Turpie; Gregory Y H Lip; Walter Ageno
Journal:  Circulation       Date:  2012-10-15       Impact factor: 29.690

Review 7.  New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper.

Authors:  Raffaele De Caterina; Steen Husted; Lars Wallentin; Felicita Andreotti; Harald Arnesen; Fedor Bachmann; Colin Baigent; Kurt Huber; Jørgen Jespersen; Steen Dalby Kristensen; Gregory Y H Lip; João Morais; Lars Hvilsted Rasmussen; Agneta Siegbahn; Freek W A Verheugt; Jeffrey I Weitz
Journal:  J Am Coll Cardiol       Date:  2012-04-17       Impact factor: 24.094
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.